TriMas (NASDAQ:TRS – Get Free Report) is scheduled to announce its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
TriMas Price Performance
TRS stock opened at $27.06 on Friday. The company’s 50-day moving average price is $25.83 and its two-hundred day moving average price is $25.82. TriMas has a 12 month low of $22.45 and a 12 month high of $28.51. The company has a quick ratio of 1.48, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. The firm has a market cap of $1.10 billion, a P/E ratio of 27.61 and a beta of 0.66.
TriMas Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $0.16 annualized dividend and a yield of 0.59%. TriMas’s dividend payout ratio is currently 16.33%.
Analysts Set New Price Targets
Get Our Latest Stock Report on TriMas
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
- Five stocks we like better than TriMas
- Canada Bond Market Holiday: How to Invest and Trade
- Battle of the Retailers: Who Comes Out on Top?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.